Ciprofloxacin in dextrose 5% side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Ciprofloxacin in dextrose 5%. Common side effects include foetal exposure during pregnancy among females and phlebitis among males.

The phase IV clinical study is created by eHealthMe based on 13 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 14, 2022

13 people who take Ciprofloxacin In Dextrose 5% and have side effects are studied.


What is Ciprofloxacin In Dextrose 5%?

Ciprofloxacin in dextrose 5% has active ingredients of ciprofloxacin. eHealthMe is studying from 14 Ciprofloxacin in dextrose 5% users for its effectiveness, alternative drugs and more.

Number of Ciprofloxacin in dextrose 5% reports submitted per year:

Ciprofloxacin in dextrose 5% side effects.

Ciprofloxacin In Dextrose 5% side effects by time on the drug*:

< 1 month:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Infusion site erythema (reddening of the skin at infusion site)
  3. Liver disorder (liver diseases)
  4. Pneumonia fungal
  5. Skin discolouration (change of skin colour)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Phlebitis (inflammation of the walls of a vein)
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  4. Pruritus (severe itching of the skin)
  5. Rash

Ciprofloxacin In Dextrose 5% side effects by gender *:

female:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Infusion site erythema (reddening of the skin at infusion site)
  3. Liver disorder (liver diseases)
  4. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  5. Skin discolouration (change of skin colour)

male:

  1. Phlebitis (inflammation of the walls of a vein)
  2. Pneumonia fungal
  3. Pruritus (severe itching of the skin)
  4. Rash

Ciprofloxacin In Dextrose 5% side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pneumonia fungal
  2. Skin discolouration (change of skin colour)

30-39:

n/a

40-49:

  1. Liver disorder (liver diseases)

50-59:

n/a

60+:

  1. Phlebitis (inflammation of the walls of a vein)
  2. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  3. Rash

* Approximation only. Some reports may have incomplete information.

Do you take Ciprofloxacin in dextrose 5%?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

How the study uses the data?

The study is based on ciprofloxacin (the active ingredients of Ciprofloxacin in dextrose 5%) and Ciprofloxacin in dextrose 5% (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Ciprofloxacin in dextrose 5%:

All Ciprofloxacin in dextrose 5% side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: